Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-01

Clinical Trial Update: Evaluation of the Minimum Effective Concentration of Bupivacaine (EC50) in Femoral Block for Analgesia by Ultrasound After Knee Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the minimum effective concentration (EC50) of bupivacaine for ultrasound-guided femoral nerve block to provide analgesia after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)

Snippet

Sponsor: Ed Carlos Rey Moura | Conditions: Knee Surgery, Postoperative Pain | Phase 4 | Status: COMPLETED